# RANITIDINE HYDROCHLORIDE
> **ANDA210681** · Abbreviated New Drug Application (Generic) · Sponsor: NOVITIUM PHARMA · Approved 2018-11-23
## Drug
- **FDA Application Number:** ANDA210681
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RANITIDINE HYDROCHLORIDE
- **Generic name:** Ranitidine Hydrochloride
- **Active ingredients:** RANITIDINE HYDROCHLORIDE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** NOVITIUM PHARMA
- **First approval:** 2018-11-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210681)
---
*AI Analytics · CC0 1.0*